Bamlanivimab is allocated by the federal government to states, territories, and federal entities on a weekly basis.
Bamlanivimab Allocation Table is current through March 2, 2021.
Distribution Weeks:
- Distribution Cycle 1 - Week 1: November 9-17, 2020
- Distribution Cycle 2 - Week 2: November 18-23, 2020
- Distribution Cycle 3 - Week 3: November 24 - December 1, 2020
- Distribution Cycle 4 - Week 4: December 2-8, 2020
- Distribution Cycle 5 - Week 5: December 9-15, 2020
- Distribution Cycle 6 - Week 6: December 16-22, 2020
- Distribution Cycle 7 - Weeks 7-8: December 22, 2020 - January 5, 2021
- Distribution Cycle 9 - Weeks 9-10: January 6-19, 2021
- Distribution Cycle 10 - Weeks 11-12: January 19-February 2, 2021
- Distribution Cycle 11 - Weeks 13-14: February 3-16, 2021
-
Distribution Cycle 12 - Weeks 15-16: February 17- March 2, 2021
States / Territories / Federal Entities |
Wk 1
Phase 1 (patient courses) |
Wk 2 Phase 1 (patient courses) |
Wk 3 Phase 2 (patient courses) |
Wk 4 Phase 2
(patient courses) |
Wk 5 Phase 2 (patient courses) |
Wk 6 Phase 2 (patient courses) |
Wks 7-8 Phase 2 (patient courses) |
Wks 9-10
Phase 2 (patient
courses) |
Wks
11-12 Phase 2 (patient
courses) |
Wks
13-14 Phase 2 (patient
courses) |
Wks
15-16 Phase 2 (patient
courses) |
Total
Patient
Courses Allocated |
---|
Alabama | 1,080 | 500 | 610 | 580 | 660 | 760 | 2,020 | 4,670 | 5,000 | 2,450 | 890 |
19,220 |
---|
Alaska | 240 | 120 | 120 | 130 | 120 | 120 | 60 | 110 | 150 | 60 | 40 |
12,70 |
---|
American Samoa | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
20 |
---|
Arizona | 1,250 | 630 | 970 | 970 | 1,230 | 1,670 | 2,940 | 3,220 | 4,310 | 2,780 | 1,420 |
21,390 |
---|
Arkansas
| 950 | 450 | 530 | 460 | 470 | 500 | 1,020 | 2,560 | 1,300 | 890 | 530 |
9,660 |
---|
Bureau of Prisons
| 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 70 |
270 |
---|
California
| 4,040 | 2,250 | 3,230 | 3,790 | 4,450 | 6,420 | 14,124 | 14,534 | 18,050 | 10,250 | 5,310 |
86,448 |
---|
Colorado | 1,980 | 1,080 | 1,320 | 1,130 | 960 | 960 | 500 | 480 | 730 | 730 | 590 |
10,460 |
---|
Commonwealth of the Northern Mariana Islands | 10 | 0 | 10 | 0 | 10 | 10 | 10 | 0 | 0 | 0 | 0 |
50 |
---|
Connecticut | 600 | 420 | 510 | 430 | 530 | 570 | 970 | 800 | 1,370 | 820 | 570 |
7,590 |
---|
Delaware | 140 | 90 | 120 | 140 | 170 | 290 | 420 | 290 | 400 | 260 | 190 |
2,510 |
---|
Department of Defense |
300 | 200 | 200 | 300 | 0 | 0 | 200 | 200 | 100 | 300 | 0 |
200 |
---|
Department of Health and Human Services | 0 | 0 | 200 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300 |
2,100 |
---|
Department of State
| 50 | 0 | 0 | 200 | 0 | 0 | 0 | 0 | 400 | 0 | 0 |
650 |
---|
District of Columbia | 90 | 50 | 60 | 90 | 70 | 80 | 225 | 325 | 220 | 160 | 110 |
1,480 |
---|
Federated States of Micronesia | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 |
---|
Florida | 3,890 | 1,730 | 2,230 | 2,150 | 2,140 | 2,370 | 5065 | 5,590 | 7,400 | 5,260 | 4,240 |
42,065 |
---|
Georgia | 1,920 | 860 | 1,010 | 940 | 1,100 | 1,440 | 3,000 | 3,880 | 4,640 | 3,600 | 2,210 |
24,600 |
---|
Guam | 50 | 100 | 50 | 20 | 10 | 10 | 10 | 10 | 30 | 10 | 0 |
300 |
---|
Hawaii | 80 | 30 | 40 | 60 | 30 | 30 | 60 | 60 | 100 | 30 | 30 |
550 |
---|
Idaho | 680 | 290 | 330 | 330 | 280 | 290 | 500 | 510 | 590 | 210 | 100 |
4,110 |
---|
Illinois |
6,380 | 2,930 | 3,160 | 2,340 | 2,080 | 2,080 | 3,730 | 3,310 | 3,320 | 1,920 | 1,240 |
32,490 |
---|
Indiana | 2,750 | 1,480 | 1,700 | 1,470 | 1,410 | 1,410 | 2,490 | 3,600 | 2,340 | 1,230 | 1,200 |
9,200 |
---|
Indian Health Service | 300 | 300 | 200 | 300 | 0 | 700 | 1,400 | 1,400 | 1,400 | 2,000 | 770 |
20,650 |
---|
Iowa | 2,110 | 1,030 | 1,030 | 680 | 510 | 510 | 747 | 847 | 800 | 430 | 320 |
9,014 |
---|
Kansas | 1,330 | 700 | 780 | 630 | 580 | 580 | 1910 | 1,780 | 1,860 | 600 | 360 |
11,110 |
---|
Kentucky | 1,980 | 920 | 1,140 | 1,030 | 1,010 | 1,220 | 2,170 | 1,800 | 1,850 | 1,850 | 1,290 |
16,260 |
---|
Louisiana | 690 | 540 | 620 | 530 | 620 | 620 | 3,444 | 6,051 | 2,156 | 1,190 | 650 |
17,111 |
---|
Maine | 90 | 50 | 60 | 60 | 70 | 80 | 170 | 170 | 360 | 140 | 90 |
1,340 |
---|
Maryland | 840
| 520 | 710 | 700 | 690 | 690 | 1,210 | 1,180 | 1,560 | 1,130 | 710 |
9,940 |
---|
Massachusetts | 1,020 | 560 | 670 | 600 | 870 | 1,010 | 1,870 | 1,600 | 1,920 | 100 | 300 |
10,520 |
---|
Michigan | 3,240 | 1,740 | 2,090 | 1,970 | 1,580 | 1,580 | 2,810 | 2,710 | 3,080 | 1,130 | 680 |
22,610 |
---|
Minnesota | 2,400 | 1,400 | 1,580 | 1,310 | 990 | 990 | 1,590 | 1,460 | 2,460 | 570 | 380 |
15,130 |
---|
Mississippi
|
660 | 330 | 420 | 410 | 430 | 910 | 3,060 | 4,329 | 1,910 | 740 | 420 |
13,619 |
---|
Missouri | 2,440 | 1,230 | 1,410 | 1,070 | 900 | 900 | 1,620 | 1,380 | 1,380 | 910 | 550 |
13,790 |
---|
Montana | 710 | 310 | 370 | 260 | 210 | 210 | 290 | 190 | 280 | 180 | 130 |
3,140 |
---|
National Institute of Health | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
50 |
---|
Nebraska | 1,170 | 570 | 630 | 490 | 480 | 480 | 940 | 940 | 1,110 | 230 | 210 |
7,250 |
---|
Nevada | 800 | 470 | 590 | 600 | 590 | 630 | 1,340 | 880 | 1,040 | 680 | 430 |
8,050 |
---|
New Hampshire | 100 | 70 | 100 | 130 | 150 | 180 | 310 | 310 | 430 | 210 | 150 |
2,140 |
---|
New Jersey | 1,550
| 980 | 1,200 | 1,190 | 1,200 | 1,300 | 2,550 | 2,040 | 3,320 | 2,510 | 1,210 |
19,050 |
---|
New Mexico | 750 | 340 | 590 | 420 | 370 | 370 | 590 | 490 | 610 | 380 | 100 |
5,010 |
---|
New York | 2,140 | 1,350 | 1,670 | 1,940 | 2,210 | 2,430 | 5,850 | 5,660 | 8,350 | 5,160 | 4,610 |
41,370 |
---|
North Carolina | 1,690 | 740 | 970 | 930 | 1,030 | 1,270 | 2,520 | 2,670 | 4,065 | 2,670 | 1,430 |
19,985 |
---|
North Dakota | 770 | 290 | 320 | 200 | 180 | 190 | 150 | 110 | 130 | 70 | 50 |
2460 |
---|
Ohio | 3,420 | 1,900 | 2,330 | 2,330 | 2,150 | 2,690 | 4,930 | 4,130 | 4,160 | 2,440 | 1,580 |
32,060 |
---|
Oklahoma | 1,230 | 770 | 940 | 910 | 770 | 790 | 1,650 | 3,687 | 1,910 | 1,370 | 800 |
14,827 |
---|
Oregon | 430 | 230 | 300 | 340 | 300 | 300 | 520 | 420 | 630 | 340 | 130 |
3,940 |
---|
Palau | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
20 |
---|
Pennsylvania | 2,300 | 1,380 | 1,870 | 1,980 | 2,180 | 2,990 | 5,120 | 4,920 | 4,920 | 2,980 | 1,880 |
32,520 |
---|
Puerto Rico | 640 | 180 | 200 | 170 | 150 | 150 | 340 | 200 | 390 | 160 | 100 |
2,680 |
---|
Republic of Marshall Islands | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 |
---|
Rhode Island | 310 | 160 | 210 | 190 | 220 | 220 | 370 | 474 | 540 | 710 | 170 |
3,574 |
---|
South Carolina | 800 | 360 | 410 | 390 | 510 | 600 | 1,832 | 3,560 | 2,350 | 1,701 | 1,340 |
13,853 |
---|
South Dakota | 820 | 340 | 340 | 240 | 230 | 230 | 460 | 430 | 510 | 90 | 70 |
3,760 |
---|
Tennessee | 1,900 | 1,080 | 1,170 | 1,130 | 1,100 | 1,560 | 3,450 | 2,790 | 2,500 | 1,340 | 650 |
18,670 |
---|
Texas | 5,780 | 3,190 | 3,840 | 3,260 | 3,160 | 4,805 | 8,130 | 9,932 | 12,660 | 8,480 | 5,750 |
68,987 |
---|
U.S. Virgin Islands | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 20 | 10 | 10 |
120 |
---|
Utah | 1,300 | 600 | 750 | 510 | 540 | 540 | 890 | 760 | 900 | 640 | 170 |
7,600 |
---|
Vermont | 20 | 20 | 30 | 20 | 30 | 40 | 100 | 40 | 100 | 70 | 40 |
510 |
---|
Veterans Health Administration | 300 | 0 | 200 | 300 | 0 | 0 | 200 | 200 |
600 | 400 | 400 |
2,600 |
---|
Virginia | 1,010 | 430 | 620 | 640 | 650 | 820 | 1,570 | 1,750 | 3,170 | 2,040 | 1,470 |
14,170 |
---|
Washington | 720 | 410 | 430 | 570 | 510 | 530 | 720 | 770 | 1,480 | 740 | 70 |
6,950 |
---|
West Virginia | 370 | 100 | 260 | 270 | 260 | 280 | 580 | 848 | 800 | 430 | 240 |
4,438 |
---|
Wisconsin | 4,260 | 1,860 | 1,990 | 1,380 | 1,110 | 1,110 | 2,190 | 2,010 | 1,970 | 950 | 560 |
19,390 |
---|
Wyoming | 330 | 160 | 200 | 140 | 110 | 110 | 160 | 110 | 220 | 80 | 50 |
1670 |
---|
All Jurisdictions (patient courses) |
79,350 |
40,980 |
49,550 |
45,760 |
44,380 |
53,635 |
107,107 |
119,187 |
130,371 | 78,911 |
49,360 |
798,591 |
---|
Current Total Monoclonal Antibody Therapeutics Allocated and Delivered
Therapeutic |
Total Allocation
(patient courses) |
Total Delivered (patient courses) |
---|
Bamlanivimab (through March 2, 2021) | 798,591 | 664,691 |
---|
Casirivimab/imdevimab (through February 2, 2021) | 148,022 | 96,923 |
---|
All Monoclonal Antibody Therapeutics |
946,613 |
761,614 |
---|
Allocation Phases
- Phase 1: allocation to hospitals and hospital-affiliated locations
- Phase 2: allocation expanded to additional outpatients facilities